NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Merck Announces Elevian as Winner of its North American Advance Biotech Grant

by Emma Jones
January 21, 2022
A A

The early-stage biotechnology company was selected for its innovative recombinant protein, which has the potential to accelerate ischemic and hemorrhagic stroke recovery.

  • Experts from the company’s M Lab™ Collaboration Center to provide production and scale-up training
  • Elevian to receive in-kind products for its treatment to support and improve stroke recovery
  • The company has awarded 39 Advance Biotech grants to 39 biotechnology companies since 2014

Merck, a leading science and technology company, today announced that Elevian has been selected as the North American winner of its 2021 Advance Biotech Grant Program. The early-stage biotechnology company, which is based in Allston, Massachusetts, USA, was selected for its innovative recombinant protein, which has the potential to accelerate ischemic and hemorrhagic stroke recovery.

“Strokes are the second leading cause of death worldwide,” said Andrew Bulpin, head of Process Solutions, Life Science at Merck. “We are pleased to support Elevian in the production and scale-up of its treatment to potentially support and improve stroke recovery.”

As part of the award, Elevian will receive in-kind products from the Life Science business sector, including the CHOZN® Expression Platform for selection and scale up, consultation services to help with upstream process development, and training provided by technical experts from the Emprove® team and the M Lab™ Collaboration Center.

Elevian is developing recombinant growth differentiation factor 11 (rGDF11) to improve recovery after stroke. rGDF11 has been demonstrated to promote functional recovery and regeneration in preclinical models of both ischemic1 and hemorrhagic2 stroke. Additionally, rGDF11 has been demonstrated to promote recovery and regeneration in preclinical models of multiple aging-related diseases including metabolic3, cardiovascular4, neurodegenerative5, and inflammatory6 diseases. Phase I clinical trials are expected to begin in early 2023.

“We are honored to have been selected as the winner of the Advance Biotech Grant,” said Dr. Mark Allen, CEO, Elevian. “The company’s extensive product portfolio, coupled with its process development and regulatory expertise will play a pivotal role in helping us scale up manufacturing of this potentially life-enhancing therapy, and we look forward to the collaboration.”

Since 2014, Merck’s Advance Biotech Grant Program has awarded technologies and consultation to 39 biotechnology companies. These grants have been used to support biotech companies whose missions are to help patients suffering from cancer, brain tumors, osteoarthritis, and cardiovascular disorders.

Tags: < Corporate Events
ShareTweetShareSend

Related Industries

Healthcare

Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation

January 26, 2023
Healthcare

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 25, 2023
Healthcare

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023
Healthcare

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023
Healthcare

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

January 7, 2023
Healthcare

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

Cargill Wins 2023 BIG Innovation Award

January 12, 2023

...

chevron finalizes acquisition of beyond6 CNG fueling network

January 4, 2023

...

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023

...

chevron names mark a. nelson vice chairman

January 27, 2023

...

The Ritz-Carlton Leadership Center Appoints Amanda Joiner as New Global Vice President

January 11, 2023

...

Barclays Expands Technology Banking Franchise with Two Senior Appointments

January 26, 2023

...

Kohler Co. Appoints Laura Kohler as Company’s First Chief Sustainability and DEI Officer

January 20, 2023

...

Ford’s John Savona to Retire in March, Closing 33-Year Career; Bryce Currie Will Lead Americas Manufacturing, Labor Affairs

January 12, 2023

...

BYD Partners with NVIDIA to Bring GeForce NOW Cloud Gaming to New Energy Vehicles

January 5, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.